174 related articles for article (PubMed ID: 31988246)
1. The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex.
Carr RM; Romecin Duran PA; Tolosa EJ; Ma C; Oseini AM; Moser CD; Banini BA; Huang J; Asumda F; Dhanasekaran R; Graham RP; Toruner MD; Safgren SL; Almada LL; Wang S; Patnaik MM; Roberts LR; Fernandez-Zapico ME
J Biol Chem; 2020 Feb; 295(9):2698-2712. PubMed ID: 31988246
[TBL] [Abstract][Full Text] [Related]
2. The human sulfatase 2 inhibitor 2,4-disulfonylphenyl-tert-butylnitrone (OKN-007) has an antitumor effect in hepatocellular carcinoma mediated via suppression of TGFB1/SMAD2 and Hedgehog/GLI1 signaling.
Zheng X; Gai X; Han S; Moser CD; Hu C; Shire AM; Floyd RA; Roberts LR
Genes Chromosomes Cancer; 2013 Mar; 52(3):225-36. PubMed ID: 23109092
[TBL] [Abstract][Full Text] [Related]
3. Activation of the transcription factor GLI1 by WNT signaling underlies the role of SULFATASE 2 as a regulator of tissue regeneration.
Nakamura I; Fernandez-Barrena MG; Ortiz-Ruiz MC; Almada LL; Hu C; Elsawa SF; Mills LD; Romecin PA; Gulaid KH; Moser CD; Han JJ; Vrabel A; Hanse EA; Akogyeram NA; Albrecht JH; Monga SPS; Sanderson SO; Prieto J; Roberts LR; Fernandez-Zapico ME
J Biol Chem; 2013 Jul; 288(29):21389-21398. PubMed ID: 23740243
[TBL] [Abstract][Full Text] [Related]
4. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
5. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Induction of Periostin by a Sulfatase 2-TGFβ1-SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma.
Chen G; Nakamura I; Dhanasekaran R; Iguchi E; Tolosa EJ; Romecin PA; Vera RE; Almada LL; Miamen AG; Chaiteerakij R; Zhou M; Asiedu MK; Moser CD; Han S; Hu C; Banini BA; Oseini AM; Chen Y; Fang Y; Yang D; Shaleh HM; Wang S; Wu D; Song T; Lee JS; Thorgeirsson SS; Chevet E; Shah VH; Fernandez-Zapico ME; Roberts LR
Cancer Res; 2017 Feb; 77(3):632-645. PubMed ID: 27872089
[TBL] [Abstract][Full Text] [Related]
7. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation.
Lai JP; Oseini AM; Moser CD; Yu C; Elsawa SF; Hu C; Nakamura I; Han T; Aderca I; Isomoto H; Garrity-Park MM; Shire AM; Li J; Sanderson SO; Adjei AA; Fernandez-Zapico ME; Roberts LR
Hepatology; 2010 Nov; 52(5):1680-9. PubMed ID: 20725905
[TBL] [Abstract][Full Text] [Related]
8. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
[TBL] [Abstract][Full Text] [Related]
9. Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma.
Zhou XT; Ding J; Li HY; Zuo JL; Ge SY; Jia HL; Wu J
J Cell Mol Med; 2020 Apr; 24(7):4298-4311. PubMed ID: 32108992
[TBL] [Abstract][Full Text] [Related]
10. Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.
Lai JP; Thompson JR; Sandhu DS; Roberts LR
Future Oncol; 2008 Dec; 4(6):803-14. PubMed ID: 19086847
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic downregulation of the suppressor of cytokine signaling 1 (Socs1) gene is associated with the STAT3 activation and development of hepatocellular carcinoma induced by methyl-deficiency in rats.
Bagnyukova TV; Tryndyak VP; Muskhelishvili L; Ross SA; Beland FA; Pogribny IP
Cell Cycle; 2008 Oct; 7(20):3202-10. PubMed ID: 18843197
[TBL] [Abstract][Full Text] [Related]
12. HERC2 promotes inflammation-driven cancer stemness and immune evasion in hepatocellular carcinoma by activating STAT3 pathway.
Liu Y; Xu Q; Deng F; Zheng Z; Luo J; Wang P; Zhou J; Lu X; Zhang L; Chen Z; Zhang Q; Chen Q; Zuo D
J Exp Clin Cancer Res; 2023 Feb; 42(1):38. PubMed ID: 36721234
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Desmoglein 2 in a Mouse Model of Gorlin Syndrome Enhances Spontaneous Basal Cell Carcinoma Formation through STAT3-Mediated Gli1 Expression.
Brennan-Crispi DM; Overmiller AM; Tamayo-Orrego L; Marous MR; Sahu J; McGuinn KP; Cooper F; Georgiou IC; Frankfurter M; Salas-Alanis JC; Charron F; Millar SE; Mahoney MG; Riobo-Del Galdo NA
J Invest Dermatol; 2019 Feb; 139(2):300-307. PubMed ID: 30291846
[TBL] [Abstract][Full Text] [Related]
14. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma.
Won C; Kim BH; Yi EH; Choi KJ; Kim EK; Jeong JM; Lee JH; Jang JJ; Yoon JH; Jeong WI; Park IC; Kim TW; Bae SS; Factor VM; Ma S; Thorgeirsson SS; Lee YH; Ye SK
Hepatology; 2015 Oct; 62(4):1160-73. PubMed ID: 26154152
[TBL] [Abstract][Full Text] [Related]
15. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
[TBL] [Abstract][Full Text] [Related]
16. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.
Mills LD; Zhang Y; Marler RJ; Herreros-Villanueva M; Zhang L; Almada LL; Couch F; Wetmore C; Pasca di Magliano M; Fernandez-Zapico ME
J Biol Chem; 2013 Apr; 288(17):11786-94. PubMed ID: 23482563
[TBL] [Abstract][Full Text] [Related]
17. A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNA.
He J; Zuo Q; Hu B; Jin H; Wang C; Cheng Z; Deng X; Yang C; Ruan H; Yu C; Zhao F; Yao M; Fang J; Gu J; Zhou J; Fan J; Qin W; Yang XR; Wang H
Cancer Lett; 2019 May; 450():98-109. PubMed ID: 30790682
[TBL] [Abstract][Full Text] [Related]
18. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
19. The transcription factor GLI1 mediates TGFβ1 driven EMT in hepatocellular carcinoma via a SNAI1-dependent mechanism.
Zheng X; Vittar NB; Gai X; Fernandez-Barrena MG; Moser CD; Hu C; Almada LL; McCleary-Wheeler AL; Elsawa SF; Vrabel AM; Shire AM; Comba A; Thorgeirsson SS; Kim Y; Liu Q; Fernandez-Zapico ME; Roberts LR
PLoS One; 2012; 7(11):e49581. PubMed ID: 23185371
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements.
Safgren SL; Olson RLO; Vrabel AM; Almada LL; Marks DL; Hernandez-Alvarado N; Gaspar-Maia A; Fernandez-Zapico ME
J Biol Chem; 2020 Jun; 295(26):8725-8735. PubMed ID: 32376693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
